Employer Quick Look
Roche Singapore Technical Operations Pte Ltd

Roche Singapore Technical Operations

Roche Singapore Technical Operations is Roche’s first biologics manufacturing
site within Asia region, and the first company in Singapore to produce US FDA
licensed bio therapeutics using recombinant DNA technologies. 

Our Vision and Mission

We will be the most admired biotechnology production operation, respected for
our world class innovation, engrained quality inspired people and operational

Quality is every patient’s right and every employee’s responsibility. Quality
provides a competitive advantage and is engrained in everything we do, from
concept through continuous improvement. Because Roche’s products touch human
lives, quality is the true measure of our success.

The Business of Improving Human Lives

With over 500 employees, two state-of-the-art facilities, using two different
production technology platforms to manufacture bacterial and mammalian
cell-based products – all within a 12.6 hectare biomedical space. Here is where
we produce the biologic medicines that target a wide spectrum of patients and
conditions.  Our facilities are designed for multi-product drug substance
manufacturing based on CHO and E.Coli platforms. The 26,000 m² CHO facility
manufactures Avastin, an anti-angiogenesis therapy for colorectal, lung,
kidney, breast and brain cancer patients; and Herceptin, a therapeutic antibody
for metastatic breast cancer.  The 3,084 m2 E.Coli facility, on the other
hand, yields Lucentis, a treatment for patients with wet age-related macular
degeneration, a leading cause of blindness in people over 55. The entire
operation is supported by external infrastructure which includes a power
substation, waste neutralization, industrial gases and water storage.